It's to do with A2M taking 100% of BAL's market share.
Read the graphs from the last 4 HY presentations from both companies and see for yourself.
Bad luck BAL holders, thankfully I sold out at 11.90 half a year ago when I knew something was going wrong. No matter how much Alterego or Barolobill upramped BAL, and downramped A2M, I still topped up A2M many times over the last year and have been rewarded each time. Backed the right horse, along with a lot of other smart investors.
Any BAL holders looking to make all their money back, head over to A2M as quick as possible.
- Forums
- ASX - By Stock
- BAL
- Ann: Suspension from Official Quotation
Ann: Suspension from Official Quotation, page-66
-
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online